Proprietary airflow system delivers high-velocity, rifled drug dispersion for precise nasal targeting.
Enables direct and rapid drug transport to the brain within minutes via neural and vascular pathways.
Temperature-stable spray-dried powders enhance absorption through the nasal lining for optimized neurological efficacy.
Enables direct brain access by bypassing the blood-brain barrier (BBB).
Achieves therapeutic effects with significantly lower dosages.
Minimizes toxicity and drug-drug interactions while enhancing safety profiles.
Non-invasive delivery increases compliance and supports use in acute field settings and home care management.
Systemic toxicity of current drugs.
Poor patient compliance due to side effects and invasive delivery methods.
Limited effectiveness of drugs failing to cross the blood-brain barrier (BBB).
Systemic breakdown of drugs in the gastrointestinal tract and liver reduces the amount of medication reaching the brain.